(Health-NewsWire.Net, May 19, 2016 ) Publisher's, 'Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2016', provides an overview of the Thrombotic Thrombocytopenic Purpura pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Thrombotic Thrombocytopenic Purpura, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Thrombotic Thrombocytopenic Purpura and features dormant and discontinued projects.
Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Thrombotic Thrombocytopenic Purpura - The report reviews pipeline therapeutics for Thrombotic Thrombocytopenic Purpura by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Thrombotic Thrombocytopenic Purpura therapeutics and enlists all their major and minor projects - The report assesses Thrombotic Thrombocytopenic Purpura therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
Inquire before Purchasing Report @ http://www.reportsweb.com/inquiry&RW0001239354/buying
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Thrombotic Thrombocytopenic Purpura - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Thrombotic Thrombocytopenic Purpura pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001239354/sample
Table of Content: An Overview
Introduction 6 Publisher Report Coverage 6 Thrombotic Thrombocytopenic Purpura Overview 7 Therapeutics Development 8 Pipeline Products for Thrombotic Thrombocytopenic Purpura - Overview 8 Pipeline Products for Thrombotic Thrombocytopenic Purpura - Comparative Analysis 9 Thrombotic Thrombocytopenic Purpura - Therapeutics under Development by Companies 10 Thrombotic Thrombocytopenic Purpura - Therapeutics under Investigation by Universities/Institutes 11 Thrombotic Thrombocytopenic Purpura - Pipeline Products Glance 12 Late Stage Products 12 Clinical Stage Products 13 Early Stage Products 14 Thrombotic Thrombocytopenic Purpura - Products under Development by Companies 15 Thrombotic Thrombocytopenic Purpura - Products under Investigation by Universities/Institutes 16 Thrombotic Thrombocytopenic Purpura - Companies Involved in Therapeutics Development 17 Ablynx NV 17 Biogen, Inc. 18 Glenmark Pharmaceuticals Ltd. 19 Kaketsuken K.K. 20 Lee's Pharmaceutical Holdings Limited 21 Octapharma AG 22 Omeros Corporation 23 Thrombotic Thrombocytopenic Purpura - Therapeutics Assessment 24
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001239354/discount
Assessment by Monotherapy Products 24 Assessment by Target 25 Assessment by Mechanism of Action 27 Assessment by Route of Administration 29 Assessment by Molecule Type 31 Drug Profiles 33 ARC-15105 - Drug Profile 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 BAX-930 - Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 caplacizumab - Drug Profile 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 GBR-600 - Drug Profile 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 OMS-721 - Drug Profile 39 Product Description 39 Mechanism of Action 39 R&D Progress 39
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001239354/buy/2000
About Us:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us: Email: sales@reportsweb.com Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|